Central Bank of India receives CCI nod for increased stakes in Generali Insurance companies

The transformation includes new names -- Generali Central Life Insurance Company and Generali Central Insurance Company Ltd -- along with new logos and a refreshed digital presence.

Central Bank of India has secured regulatory approval from the Competition Commission of India (CCI) to increase its shareholding in two Generali insurance subsidiaries.

The approval, dated March 3, 2026, marks a significant step in the bank's strategic expansion in the insurance sector.

The Competition Commission of India approved the proposed combination dated March 3, 2026. The approval was granted under Section 31(1) of the Competition Act, 2002, following the Commission's meeting held on the same date.

The approved transaction involves Central Bank of India acquiring additional equity stakes in two insurance companies within the Generali group. The bank will purchase 1.09 percent additional equity in Generali Central Insurance Company Limited (GCICL) and 0.82 percent additional equity in Generali Central Life Insurance Company Limited (GCLICL).

This would make stakes in both companies 26 percent each.

The bank had previously informed the stock exchanges about this proposed acquisition on November 6, 2025. The current disclosure was made under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring full transparency with shareholders and regulatory authorities.

This acquisition will strengthen Central Bank of India's position in both general and life insurance segments through its partnership with the Generali group. The uniform 26 percent shareholding in both companies will provide the bank with enhanced influence in the strategic direction of these insurance entities while maintaining compliance with regulatory ownership limits, according to the filing.